TEVOGEN BIO HLDGS INC
COM · CUSIP 88165K101
6
institutional holders
6.8m
shares reported held*
$30.7mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.53.
Biggest buyers
| Portland Global Advisors LLC | New | +5.8m |
| CANTOR FITZGERALD, L. P. | New | +650.0k |
| Polar Asset Management Partners Inc. | New | +334.6k |
| HRT FINANCIAL LP | New | +12.3k |
| JPMORGAN CHASE & CO | New | +60 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | New | 0 |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Saadi Ryan H.
13D · may seek influence
-2.3 pts · filed 2026-07-14
Stated purposeItem 4 of the Schedule 13D is hereby amended and supplemented by adding the following: The information set forth in Items 3 and 6 of this Amendment is incorporated into this Item 4 by reference. Full filing |
59.7% |
Holders, Q1 2024
| Manager | Shares | Change |
|---|---|---|
| Portland Global Advisors LLC 2.96% of their portfolio | 5.8m $21.7m | New |
| CANTOR FITZGERALD, L. P. 0.66% of their portfolio | 650.0k $2.8m | New |
| Polar Asset Management Partners Inc. 0.17% of their portfolio | 334.6k $6.2m | New |
| HRT FINANCIAL LP 0.00% of their portfolio | 12.3k $45.0k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 60 $224 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |